Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|July 26, 2013
The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseasesJenny Lam, Nichole Coleman, April Lourdes A Garing, et al.
Frontiers in Pharmacology|June 12, 2012
Triarylmethanes, a new class of cx50 inhibitorsSilke B Bodendiek, Clio Rubinos, Maria Pilar Trelles, et al.
Molecular Pharmacology|June 25, 2014
New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1Nichole Coleman, Brandon M Brown, Aida Oliván-Viguera, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2014
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsantNichole Coleman, Hai M Nguyen, Zhengyu Cao, et al.
Plos One|February 27, 2024
Virtual BUILD Research Collaboratory: A biomedical data science training using innovative pedagogy to address structures of racism and inequitable stress for undergraduates of colorNiquo Ceberio, Peter Le, Jasmón Bailey, et al.
Basic & Clinical Pharmacology & Toxicology|January 29, 2016
Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular BedAida Oliván-Viguera, Marta Sofía Valero, Estéfano Pinilla, et al.
Pageof 1